Global Autologous Cell Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Region:Global
Product Code:GIR1906130005
July 2019
102
About the Report
Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.
Scope of the Report:
The global Autologous Cell Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Autologous Cell Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Autologous Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Autologous Cell Therapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
BioTime
Pharmicell
BrainStorm Cell Therapeutics
Opexa Therapeutics
Vericel Corporation
Regeneus
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Bone Marrow
Epidermis
Market Segment by Applications, can be divided into
Neurology
Orthopedics
Cancer
Wound Healing
Other
Scope of the Report
Products
Companies
BioTime
Pharmicell
BrainStorm Cell Therapeutics
Opexa Therapeutics
Vericel Corporation
Regeneus
Table of Contents
Table of Contents
1 Autologous Cell Therapy Market Overview
1.1 Product Overview and Scope of Autologous Cell Therapy
1.2 Classification of Autologous Cell Therapy by Types
1.2.1 Global Autologous Cell Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Autologous Cell Therapy Revenue Market Share by Types in 2018
1.2.3 Bone Marrow
1.2.4 Epidermis
1.3 Global Autologous Cell Therapy Market by Application
1.3.1 Global Autologous Cell Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Neurology
1.3.3 Orthopedics
1.3.4 Cancer
1.3.5 Wound Healing
1.3.6 Other
1.4 Global Autologous Cell Therapy Market by Regions
1.4.1 Global Autologous Cell Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Autologous Cell Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Autologous Cell Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autologous Cell Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Autologous Cell Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autologous Cell Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Autologous Cell Therapy (2014-2024)
2 Company Profiles
2.1 BioTime
2.1.1 Business Overview
2.1.2 Autologous Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BioTime Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pharmicell
2.2.1 Business Overview
2.2.2 Autologous Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pharmicell Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 BrainStorm Cell Therapeutics
2.3.1 Business Overview
2.3.2 Autologous Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Opexa Therapeutics
2.4.1 Business Overview
2.4.2 Autologous Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Opexa Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Vericel Corporation
2.5.1 Business Overview
2.5.2 Autologous Cell Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Vericel Corporation Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Regeneus
2.6.1 Business Overview
2.6.2 Autologous Cell Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Regeneus Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Autologous Cell Therapy Market Competition, by Players
3.1 Global Autologous Cell Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Autologous Cell Therapy Players Market Share
3.2.2 Top 10 Autologous Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Global Autologous Cell Therapy Market Size by Regions
4.1 Global Autologous Cell Therapy Revenue and Market Share by Regions
4.2 North America Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
5 North America Autologous Cell Therapy Revenue by Countries
5.1 North America Autologous Cell Therapy Revenue by Countries (2014-2019)
5.2 USA Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
6 Europe Autologous Cell Therapy Revenue by Countries
6.1 Europe Autologous Cell Therapy Revenue by Countries (2014-2019)
6.2 Germany Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
6.4 France Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Autologous Cell Therapy Revenue by Countries
7.1 Asia-Pacific Autologous Cell Therapy Revenue by Countries (2014-2019)
7.2 China Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
7.5 India Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
8 South America Autologous Cell Therapy Revenue by Countries
8.1 South America Autologous Cell Therapy Revenue by Countries (2014-2019)
8.2 Brazil Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Autologous Cell Therapy by Countries
9.1 Middle East and Africa Autologous Cell Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Autologous Cell Therapy Revenue and Growth Rate (2014-2019)
10 Global Autologous Cell Therapy Market Segment by Type
10.1 Global Autologous Cell Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Autologous Cell Therapy Market Forecast by Type (2019-2024)
10.3 Bone Marrow Revenue Growth Rate (2014-2024)
10.4 Epidermis Revenue Growth Rate (2014-2024)
11 Global Autologous Cell Therapy Market Segment by Application
11.1 Global Autologous Cell Therapy Revenue Market Share by Application (2014-2019)
11.2 Autologous Cell Therapy Market Forecast by Application (2019-2024)
11.3 Neurology Revenue Growth (2014-2019)
11.4 Orthopedics Revenue Growth (2014-2019)
11.5 Cancer Revenue Growth (2014-2019)
11.6 Wound Healing Revenue Growth (2014-2019)
11.7 Other Revenue Growth (2014-2019)
12 Global Autologous Cell Therapy Market Size Forecast (2019-2024)
12.1 Global Autologous Cell Therapy Market Size Forecast (2019-2024)
12.2 Global Autologous Cell Therapy Market Forecast by Regions (2019-2024)
12.3 North America Autologous Cell Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Autologous Cell Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Autologous Cell Therapy Revenue Market Forecast (2019-2024)
12.6 South America Autologous Cell Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Autologous Cell Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Research Methodology
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.